A Phase II, Multicentre Trial of Decitabine in Higher-Risk Chronic Myelomonocytic Leukemia.

V Santini,B Allione,G Zini,D Gioia,M Lunghi,A Poloni,D Cilloni,A Sanna,E Masiera,M Ceccarelli,O Abdel-Wahab,A Terenzi,E Angelucci,C Finelli,F Onida,A Pelizzari,D Ferrero,G Saglio,M Figueroa,A Levis

Leukemia（2017）

Cited 62|Views80

Key words

Myelodysplastic syndrome,Phase II trials,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined